400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Protein Tyrosine Kinase/RTK / Src / WH-4-023
CAS No.: 837422-57-8
Synonyms: Dual LCK/SRC inhibitor;KIN-001112;KIN-112
WH-4-023 is an inhibitor of Lck and Src with IC50 of 2 nM, 6 nM, respectively.
生物活性
靶点 | Lck IC50:2nM | Src IC50:6nM |
实验方案
技术信息
CAS号 | 837422-57-8 | 储存条件 |
|
|||||||||||
分子式 | C32H36N6O4 | 运输 | 蓝冰 | |||||||||||
分子量 | 568.67 | 别名 | Dual LCK/SRC inhibitor;KIN-001112;KIN-112 | |||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
A498 cell | - | Growth inhibition assay | - | Inhibition of human A498 cell growth in a cell viability assay, IC50=0.18945 μM | SANGER |
COLO-829 cell | - | Growth inhibition assay | - | Inhibition of human COLO-829 cell growth in a cell viability assay, IC50=0.31212 μM | SANGER |
human A388 cell | - | Growth inhibition assay | - | Inhibition of human A388 cell growth in a cell viability assay, IC50=14.6758 μM | SANGER |
human A704 cell | - | Growth inhibition assay | - | Inhibition of human A704 cell growth in a cell viability assay, IC50=0.00127 μM | SANGER |
human BB30-HNC cell | - | Growth inhibition assay | - | Inhibition of human BB30-HNC cell growth in a cell viability assay, IC50=1.85472 μM | SANGER |
human Becker cell | - | Growth inhibition assay | - | Inhibition of human Becker cell growth in a cell viability assay, IC50=0.06381 μM | SANGER |
human BL-41 cell | - | Growth inhibition assay | - | Inhibition of human BL-41 cell growth in a cell viability assay, IC50=1.00013 μM | SANGER |
human BL-70 cell | - | Growth inhibition assay | - | Inhibition of human BL-70 cell growth in a cell viability assay, IC50=4.72e-05 μM | SANGER |
human BOKU cell | - | Growth inhibition assay | - | Inhibition of human BOKU cell growth in a cell viability assay, IC50=1.80527 μM | SANGER |
human BV-173 cell | - | Growth inhibition assay | - | Inhibition of human BV-173 cell growth in a cell viability assay, IC50=0.000514 μM | SANGER |
human CTV-1 cell | - | Growth inhibition assay | - | Inhibition of human CTV-1 cell growth in a cell viability assay, IC50=3.18e-05 μM | SANGER |
human D-263MG cell | - | Growth inhibition assay | - | Inhibition of human D-263MG cell growth in a cell viability assay, IC50=2.28853 μM | SANGER |
human D-336MG cell | - | Growth inhibition assay | - | Inhibition of human D-336MG cell growth in a cell viability assay, IC50=0.04681 μM | SANGER |
human Daudi cell | - | Growth inhibition assay | - | Inhibition of human Daudi cell growth in a cell viability assay, IC50=0.71411 μM | SANGER |
human DMS-114 cell | - | Growth inhibition assay | - | Inhibition of human DMS-114 cell growth in a cell viability assay, IC50=2.79022 μM | SANGER |
human DOHH-2 cell | - | Growth inhibition assay | - | Inhibition of human DOHH-2 cell growth in a cell viability assay, IC50=0.000597 μM | SANGER |
human EM-2 cell | - | Growth inhibition assay | - | Inhibition of human EM-2 cell growth in a cell viability assay, IC50=3.91e-08 μM | SANGER |
human EoL-1-cell cell | - | Growth inhibition assay | - | Inhibition of human EoL-1-cell cell growth in a cell viability assay, IC50=9.51e-06 μM | SANGER |
human ES6 cell | - | Growth inhibition assay | - | Inhibition of human ES6 cell growth in a cell viability assay, IC50=2.05401 μM | SANGER |
human GB-1 cell | - | Growth inhibition assay | - | Inhibition of human GB-1 cell growth in a cell viability assay, IC50=1.16064 μM | SANGER |
human GCIY cell | - | Growth inhibition assay | - | Inhibition of human GCIY cell growth in a cell viability assay, IC50=1.2301 μM | SANGER |
human HOP-62 cell | - | Growth inhibition assay | - | Inhibition of human HOP-62 cell growth in a cell viability assay, IC50=0.91599 μM | SANGER |
human HT-144 cell | - | Growth inhibition assay | - | Inhibition of human HT-144 cell growth in a cell viability assay, IC50=1.44517 Μm | SANGER |
human IST-SL2 cell | - | Growth inhibition assay | - | Inhibition of human IST-SL2 cell growth in a cell viability assay, IC50=1.47421 μM | SANGER |
human K-562 cell | - | Growth inhibition assay | - | Inhibition of human K-562 cell growth in a cell viability assay, IC50=0.000162 μM | SANGER |
human KGN cell | - | Growth inhibition assay | - | Inhibition of human KGN cell growth in a cell viability assay, IC50=1.0521 μM | SANGER |
human KINGS-1 cell | - | Growth inhibition assay | - | Inhibition of human KINGS-1 cell growth in a cell viability assay, IC50=1.96897 μM | SANGER |
human KLE cell | - | Growth inhibition assay | - | Inhibition of human KLE cell growth in a cell viability assay, IC50=1.86232 μM | SANGER |
human KS-1 cell | - | Growth inhibition assay | - | Inhibition of human KS-1 cell growth in a cell viability assay, IC50=0.07758 μM | SANGER |
human LAMA-84 cell | - | Growth inhibition assay | - | Inhibition of human LAMA-84 cell growth in a cell viability assay, IC50=3.78e-06 μM | SANGER |
human LB1047-RCC cell | - | Growth inhibition assay | - | Inhibition of human LB1047-RCC cell growth in a cell viability assay, IC50=0.07592 μM | SANGER |
human LB2518-MEL cell | - | Growth inhibition assay | - | Inhibition of human LB2518-MEL cell growth in a cell viability assay, IC50=0.04667 μM | SANGER |
human LB996-RCC cell | - | Growth inhibition assay | - | Inhibition of human LB996-RCC cell growth in a cell viability assay, IC50=0.05668 μM | SANGER |
human LC-2-ad cell | - | Growth inhibition assay | - | Inhibition of human LC-2-ad cell growth in a cell viability assay, IC50=0.02033 μM | SANGER |
human LXF-289 cell | - | Growth inhibition assay | - | Inhibition of human LXF-289 cell growth in a cell viability assay, IC50=1.27256 μM | SANGER |
human MEG-01 cell | - | Growth inhibition assay | - | Inhibition of human MEG-01 cell growth in a cell viability assay, IC50=1.63e-05 μM | SANGER |
human MLMA cell | - | Growth inhibition assay | - | Inhibition of human MLMA cell growth in a cell viability assay, IC50=1.9231 μM | SANGER |
human MPP-89 cell | - | Growth inhibition assay | - | Inhibition of human MPP-89 cell growth in a cell viability assay, IC50=0.08229 μM | SANGER |
human NB17 cell | - | Growth inhibition assay | - | Inhibition of human NB17 cell growth in a cell viability assay, IC50=2.62875 μM | SANGER |
human NB6 cell | - | Growth inhibition assay | - | Inhibition of human NB6 cell growth in a cell viability assay, IC50=1.69698 μM | SANGER |
human NCI-H747 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50=5.74159 μM | SANGER |
human NCI-SNU-16 cell | - | Growth inhibition assay | - | Inhibition of human NCI-SNU-16 cell growth in a cell viability assay, IC50=0.01572 μM | SANGER |
human NOS-1 cell | - | Growth inhibition assay | - | Inhibition of human NOS-1 cell growth in a cell viability assay, IC50=0.95045 μM | SANGER |
human RXF393 cell | - | Growth inhibition assay | - | Inhibition of human RXF393 cell growth in a cell viability assay, IC50=0.10633 μM | SANGER |
human SF126 cell | - | Growth inhibition assay | - | Inhibition of human SF126 cell growth in a cell viability assay, IC50=1.73178 μM | SANGER |
human SF268 cell | - | Growth inhibition assay | - | Inhibition of human SF268 cell growth in a cell viability assay, IC50=2.48682 μM | SANGER |
human SH-4 cell | - | Growth inhibition assay | - | Inhibition of human SH-4 cell growth in a cell viability assay, IC50=2.12055 μM | SANGER |
human SW962 cell | - | Growth inhibition assay | - | Inhibition of human SW962 cell growth in a cell viability assay, IC50=1.33742 μM | SANGER |
human TGBC24TKB cell | - | Growth inhibition assay | - | Inhibition of human TGBC24TKB cell growth in a cell viability assay, IC50=1.03831 μM | SANGER |
human TK10 cell | - | Growth inhibition assay | - | Inhibition of human TK10 cell growth in a cell viability assay, IC50=1.08418 μM | SANGER |
HUTU-80 cell | - | Growth inhibition assay | - | Inhibition of human HUTU-80 cell growth in a cell viability assay, IC50=0.17529 μM | SANGER |
IST-MES1 cell | - | Growth inhibition assay | - | Inhibition of human IST-MES1 cell growth in a cell viability assay, IC50=0.35723 μM | SANGER |
LB831-BLC cell | - | Growth inhibition assay | - | Inhibition of human LB831-BLC cell growth in a cell viability assay, IC50=0.12715 μM | SANGER |
MC116 cell | - | Growth inhibition assay | - | Inhibition of human MC116 cell growth in a cell viability assay, IC50=2.85704 μM | SANGER |
MFH-ino cell | - | Growth inhibition assay | - | Inhibition of human MFH-ino cell growth in a cell viability assay, IC50=0.23925 μM | SANGER |
MZ1-PC cell | - | Growth inhibition assay | - | Inhibition of human MZ1-PC cell growth in a cell viability assay, IC50=0.22716 μM | SANGER |
NCI-H1648 cell | - | Growth inhibition assay | - | Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50=0.51582 μM | SANGER |
NTERA-S-cl-D1 cell | - | Growth inhibition assay | - | Inhibition of human NTERA-S-cl-D1 cell growth in a cell viability assay, IC50=0.28855 μM | SANGER |
OS-RC-2 cell | - | Growth inhibition assay | - | Inhibition of human OS-RC-2 cell growth in a cell viability assay, IC50=0.35011 μM | SANGER |
PF-382 cell | - | Growth inhibition assay | - | Inhibition of human PF-382 cell growth in a cell viability assay, IC50=0.70763 μM | SANGER |
RCC10RGB cell | - | Growth inhibition assay | - | Inhibition of human RCC10RGB cell growth in a cell viability assay, IC50=0.42631 μM | SANGER |
RL95-2 cell | - | Growth inhibition assay | - | Inhibition of human RL95-2 cell growth in a cell viability assay, IC50=1.32436 μM | SANGER |
SNB75 cell | - | Growth inhibition assay | - | Inhibition of human SNB75 cell growth in a cell viability assay, IC50=0.35774 μM | SANGER |
SW684 cell | - | Growth inhibition assay | - | Inhibition of human SW684 cell growth in a cell viability assay, IC50=0.32588 μM | SANGER |
SW872 cell | - | Growth inhibition assay | - | Inhibition of human SW872 cell growth in a cell viability assay, IC50=0.86458 μM | SANGER |
SW954 cell | - | Growth inhibition assay | - | Inhibition of human SW954 cell growth in a cell viability assay, IC50=0.37163 μM | SANGER |
SW982 cell | - | Growth inhibition assay | - | Inhibition of human SW982 cell growth in a cell viability assay, IC50=0.85819 μM | SANGER |
TE-12 cell | - | Growth inhibition assay | - | Inhibition of human TE-12 cell growth in a cell viability assay, IC50=0.88831 μM | SANGER |
TE-15 cell | - | Growth inhibition assay | - | Inhibition of human TE-15 cell growth in a cell viability assay, IC50=0.24276 μM | SANGER |
TE-8 cell | - | Growth inhibition assay | - | Inhibition of human TE-8 cell growth in a cell viability assay, IC50=0.23924 μM | SANGER |
VA-ES-BJ cell | - | Growth inhibition assay | - | Inhibition of human VA-ES-BJ cell growth in a cell viability assay, IC50=0.4626 μM | SANGER |
靶点 | Description | IC50 |
---|---|---|
Lck | IC50:2nM | |
Src | IC50:6nM |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网